Ligustrazine Attenuates Myocardial Injury Induced by Coronary Microembolization in Rats by Activating the PI3K/Akt Pathway.

Published in: Oxidative medicine and cellular longevity (2019)

Ligustrazine attenuates CME-induced myocardial injury. The effects associated with this attenuation may be achieved by activating the myocardium PI3K/Akt signaling pathway.

Keyphrases

signaling pathway
pi k akt
cell cycle arrest
induced apoptosis
epithelial mesenchymal transition
coronary artery
coronary artery disease
high glucose
diabetic rats
cell proliferation
drug induced
heart failure
aortic stenosis
stress induced